Best Immuno-Oncology Conference In UK In 2026
The Immuno-Oncology & Biomarker Summit 2026 is set to be one of the most influential life sciences events in the UK, bringing together global leaders, researchers, clinicians, and industry innovators at the forefront of cancer immunotherapy and biomarker discovery. Taking place on 16–17 March 2026 at the Millennium Hotel and Conference Centre Gloucester London, this premier summit offers an essential platform for collaboration, knowledge sharing, and scientific advancement.
As immuno-oncology continues to transform cancer treatment, the summit will focus on the latest breakthroughs in immune-based therapies, predictive and prognostic biomarkers, precision medicine, and translational research. Attendees will gain deep insights into how biomarkers are shaping patient stratification, clinical trial design, and therapeutic decision-making across oncology indications.
The conference agenda features expert-led keynote presentations, panel discussions, and technical sessions covering emerging trends, real-world challenges, and future opportunities in immuno-oncology. Topics include novel immune checkpoint strategies, combination therapies, resistance mechanisms, AI-driven biomarker discovery, and regulatory considerations impacting drug development.
Designed for professionals across biotech, pharma, academia, diagnostics, and clinical research, the Immuno-Oncology & Biomarker Summit 2026 provides unparalleled networking opportunities with senior decision-makers and scientific thought leaders. The event encourages meaningful dialogue between discovery, development, and clinical implementation, helping accelerate the journey from innovation to patient impact.
Hosted in the heart of London, the Millennium Hotel and Conference Centre Gloucester offers a world-class venue for learning and collaboration. Whether you are driving research, advancing clinical trials, or shaping commercial strategy, this summit is a must-attend event for anyone committed to the future of cancer immunotherapy.
Join us in March 2026 at the UK’s leading immuno-oncology conference and be part of shaping the next generation of cancer treatment.
This two-day event is dedicated to advancing innovation in cancer immunotherapy and biomarker science. The agenda will cover the latest in antibody-drug conjugates (ADCs), bispecific antibodies, cellular therapies, immune checkpoint inhibitors, and novel combination strategies, along with insights into pre-clinical research, translational approaches, and the evolution of personalized immunotherapy.
A strong emphasis will be placed on biomarker discovery, immune monitoring, vaccine development, and the integration of multi-omic platforms. Through cutting-edge sessions and expert-led discussions, the summit will highlight how scientific breakthroughs are reshaping oncology and driving the development of more precise, effective cancer treatments.
